For citations:
Ananyeva LP, Starovoytova MN, Gaydukova IZ, Lukina GV, Zonova EV, Eliseeva LV, Fatkhullina GF, Abdulganieva DI, Krechikova DG, Kropotina TV, Nesmeyanova OB, Vinogradova IB, Zhugrova ES, Ivanova LV, Nikulenkova NE, Ziganshin OR, Plaksina TV, Zlobin MV, Grabovetskaya YY, Soroka NF, Ershova OB, Povarova TV, Anoshenkova ON, Lutsky AA, Zinkina-Orikhan AV, Linkova YN, Fokina EA, Porozova AA, Eremeeva AV. Efficacy of divozilimab in the treatment of systemic sclerosis: results of the randomized phase III clinical trial BCD-132-5/LIBERIUS. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2025;19(1):44-48. https://doi.org/10.14412/1996-7012-2025-1-44-48
Email this article 